Abstract
Meningococcal septicaemia is a devastating disease with the potential to develop severe vascular complications. The incidence in Northern Ireland has risen from 27 cases notified in 1992 to 56 notified in 1997. We describe the first use of protein C concentrate in addition to antithrombin III infusion in the management of a life-threatening case of meningococcal septicaemia in the Regional Intensive Care Unit, Royal Group of Hospitals, Belfast, UK. The rationale and the evidence to support the use of protein C concentrate are discussed. Despite the apparent efficacy and safety of this treatment, subsequent cases of meningococcal septicaemia have not received protein C concentrate due to a lack of availability.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: 16 March 1999 Final revision received: 17 November 1999 Accepted: 1 February 2000
Rights and permissions
About this article
Cite this article
Clarke, R., Johnston, J. & Mayne, E. Meningococcal septicaemia: treatment with protein C concentrate. Intensive Care Med 26, 471–473 (2000). https://doi.org/10.1007/s001340051184
Issue Date:
DOI: https://doi.org/10.1007/s001340051184